RI
ABUS icon

RTW Investments’s Arbutus Biopharma ABUS Stock Holding History

RTW Investments’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,504,493
Closed -$9.74M – 107
2021
Q4 		$9.74M Sell
2,504,493
-2,228,830
-47% -$8.66M 0.14% 82
2021
Q3 		$20.3M Sell
4,733,323
-1,245,032
-21% -$4.15M 0.31% 62
2021
Q2 		$18.1M Hold
5,978,355
– – 0.27% 60
2021
Q1 		$19.9M Hold
5,978,355
– – 0.31% 60
2020
Q4 		$21.2M Hold
5,978,355
– – 0.36% 55
2020
Q3 		$18.7M Sell
5,978,355
-890,926
-13% -$2.71M 0.45% 51
2020
Q2 		$12.5M Hold
6,869,281
– – 0.35% 51
2020
Q1 		$6.94M Buy
6,869,281
+1,202,527
+21% +$3.25M 0.3% 50
2019
Q4 		$15.8M Buy
5,666,754
+103,787
+2% +$168K 0.59% 37
2019
Q3 		$8.48M Buy
5,562,967
+29,874
+0.5% +$51.5K 0.5% 40
2019
Q2 		$11.5M Buy
5,533,093
+22,870
+0.4% +$58.5K 0.61% 34
2019
Q1 		$19.7M Buy
5,510,223
+1,174,477
+27% +$4.51M 1.35% 24
2018
Q4 		$16.6M Buy
4,335,746
+250,842
+6% +$1.24M 1.52% 18
2018
Q3 		$38.6M Sell
4,084,904
-1,080,595
-21% -$10.7M 2.31% 12
2018
Q2 		$37.7M Buy
5,165,499
+13,884
+0.3% +$82.6K 2.72% 11
2018
Q1 		$25.8M Hold
5,151,615
– – 2.45% 12
2017
Q4 		$26M Sell
5,151,615
-114,665
-2% -$672K 4.34% 9
2017
Q3 		$32.7M Buy
5,266,280
+56,457
+1% +$241K 5.69% 8
2017
Q2 		$18.8M Buy
5,209,823
+3,763,236
+260% +$12.9M 3.95% 7
2017
Q1 		$4.7M Buy
+1,446,587
New +$4.01M 1.24% 20

Other funds holding ABUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

RTW Investments's ABUS Position: Q1 2022 in Review

RTW Investments sold out of Arbutus Biopharma (ABUS) in Q1 2022, closing a stake of 2,504,493 shares — an estimated $9.74M sold.

RTW Investments first reported a position in ABUS in Q1 2017 and held it in 20 quarters. The position peaked at $38.6M in Q3 2018. 119 funds tracked by Wall St. Rank hold ABUS as of Q1 2022.

  • RTW Investments reported no remaining Arbutus Biopharma position as of Q1 2022 after selling out during the quarter.
  • RTW Investments sold 2,504,493 Arbutus Biopharma shares in Q1 2022, an estimated $9.74M.
  • RTW Investments first reported a position in Arbutus Biopharma in Q1 2017 and held it in 20 quarters.
  • RTW Investments's Arbutus Biopharma position peaked at $38.6M in Q3 2018.
  • 119 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2022.

Based on RTW Investments's 13F filing for Q1 2022, filed 16 May 2022.